1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1109KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Pharmacists tackle dispensing by doctors |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 3-4
Jo Barnes,
Preview
|
PDF (2093KB)
|
|
摘要:
The Community Pharmacy Section of the International Pharmaceutical Federation (FIP) set up a Working Group in 1993 to examine the issue of dispensing by doctors, and to identify ways of convincing governments and ‘third-party payers’ of the value of a full pharmaceutical service. Mr Stephen Axon, Secretary of the Pharmaceutical Services Negotiating Committee, from Aylesbury, UK, presented the Working Group's findings at the 55th World Congress of Pharmacy and Pharmaceutical Sciences [Stockholm, Sweden; August 1995].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
Beyond meta-analysis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1053KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
Aspirin prophylaxis of colorectal cancer debated |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 5-5
&NA;,
Preview
|
PDF (992KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1058KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
Support for immunoglobulin prophylaxis in premature neonates |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1035KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
New treatments for breast cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 8-9
Robert H Carlson,
Preview
|
PDF (2090KB)
|
|
摘要:
In the course of developing new drugs to treat cancer, researchers have developed less toxic formulations of currently used active compounds. At the 18th San Antonio Breast Cancer Symposium [San Antonio, Texas, US; December 1995], the results of phase I and II trials of liposome-encapsulated formulations of doxorubicin and daunorubicin were presented. Currently, the new formulations appear to be better tolerated, but less effective, than standard preparations.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
IL-13 moderates post-trauma monocyte inflammatory response |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 9-9
&NA;,
Preview
|
PDF (1023KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
Anti-IL-6 antibody improves survival in sepsis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1026KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
Balancing act with chemokines in angiogenesis & inflammation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1020,
1996,
Page 11-11
Gill Higgins,
Preview
|
PDF (1017KB)
|
|
摘要:
Two functional types of chemokines have been identified. Researchers believe that any upset in the balance of these 2 groups can lead to the onset of certain pathological processes, such as tumour development and inflammation. But correction of the imbalance may well lead to disease improvement. Progress in the balancing act was reported at the IBC USA conference on Chemotactic Cytokines [Philadelphia, US; October 1995]. Studies looking specifically at the effects of interleukin-8 (IL-8) blockade in models of acute lung inflammation were also presented.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|